Carlsmed, Inc.
CARLNasdaqCIK 1794546HealthcareFiscal year ends Dec 31
Reports and events: 19 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-3009:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001794546-26-000020 |
| 2026-09-0816:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001794546-26-000018 |
| 2026-08-0516:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001794546-26-000016 |
| 2026-08-0516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001794546-26-000015 |
| 2026-06-0316:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-255404 |
| 2026-05-0516:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001794546-26-000011 |
| 2026-05-0516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001794546-26-000010 |
| 2026-04-2208:30 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001794546-26-000005 |
| 2026-02-2516:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-071551 |
| 2026-02-2516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071512 |
| 2026-01-1208:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009828 |
| 2025-11-0616:13 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269545 |
| 2025-11-0616:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269469 |
| 2025-10-3016:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-258525 |
| 2025-08-2816:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-111953 |
| 2025-08-2816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-111947 |
| 2025-07-2416:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-098327 |
| 2025-07-1506:39 ET | S-1/A | Registration statement, amended | 0000950170-25-095710 |
| 2025-06-2611:30 ET | S-1 | Registration statement | 0000950123-25-006117 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 09:38 ET. Listed shows no prices and gives no investment advice.